Physician

Jumana Chatiwala, M.D.

According to 2025 Medicare claims, Jumana Chatiwala, M.D. (NPI: 1215066980) practices hematology in the Newark, NJ market, with the plurality of this provider's patient population coming from Sussex, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07871-2625.

Chatiwala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 940 traditional Medicare patients, billed 245,548 HCPCS/CPT codes, and received $4,255,935 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,118 prescription claims across 349 beneficiaries totaling $4,520,352 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 213 claims. Open Payments data shows 23 records totaling $1,466. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $828,628 to $4,255,935. Similarly, Part D prescription costs have moved sharply higher in recent years, from $273,157 to $4,520,352. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,296 and ending at $1,575.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	371	70,768	$828,628
2016	454	95,461	$736,663
2017	482	116,238	$1,299,906
2018	568	150,484	$1,236,821
2019	590	149,640	$1,293,909
2020	731	224,344	$2,778,321
2021	763	249,439	$2,819,900
2022	852	240,335	$3,466,025
2023	849	238,724	$3,015,114
2024	940	245,548	$4,255,935

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	328	$273,157
2016	94	695	$721,876
2017	113	651	$624,988
2018	129	718	$896,182
2019	149	877	$1,726,366
2020	238	1,115	$2,246,047
2021	259	1,374	$2,328,095
2022	295	1,581	$2,841,545
2023	309	1,778	$3,519,557
2024	349	2,118	$4,520,352

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$488
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$928
2021	N/R	12	$832
2022	N/R	32	$992
2023	22	116	$8,631
2024	N/R	213	$31,021

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	627	2,031	$105
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	163	396	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	232	766	$14
36415	Insertion of needle into vein for collection of blood sample	266	696	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	687	2,626	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	64	1,890	$1,054,809
Revlimid	Lenalidomide	63	1,757	$908,838
Pomalyst	Pomalidomide	27	665	$484,728
Venclexta	Venetoclax	58	1,642	$232,697
Lenalidomide	Lenalidomide	24	672	$230,727

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4197	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix	N	N/R	16	$16,774
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	23	$5,962
B4224	Parenteral nutrition administration kit, per day	N	N/R	23	$2,721
J8521	Capecitabine, oral, 500 mg	N	N/R	35	$1,327
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$1,234

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$1,466	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Jumana Chatiwala, M.D.?

Tedicare shows public-source Medicare data for Jumana Chatiwala, M.D. (NPI 1215066980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jumana Chatiwala, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jumana Chatiwala, M.D.?

Jumana Chatiwala, M.D. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Jumana Chatiwala, M.D. have Open Payments data?

Jumana Chatiwala, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.